A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia

A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia

NCT03875534 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

NCT03197766 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia

NCT05353192 ·Status: UNKNOWN ·Phase: PHASE4

An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

NCT03424018 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)

NCT02724228 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Assess Growth in Children With Idiopathic Short Stature

NCT06309979 ·Status: RECRUITING

Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)

NCT04035811 ·Status: COMPLETED

Achondroplasia Natural History Multicenter Clinical Study

NCT02597881 ·Status: RECRUITING

Lifetime Impact of Achondroplasia Study in Europe-LIAISE

NCT03449368 ·Status: COMPLETED

An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia

NCT03989947 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia

NCT07297875 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.

NCT06732895 ·Status: RECRUITING ·Phase: PHASE2

Testing the Feasibility of a Novel Growth Monitoring Smartphone App

NCT05829252 ·Status: COMPLETED

A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia

NCT06433557 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Growth Retardation In Children With Special Pathological Conditions Or Disease

NCT00163215 ·Status: COMPLETED ·Phase: PHASE3

Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients

NCT05858606 ·Status: RECRUITING ·Phase: NA

Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)

NCT05328050 ·Status: RECRUITING

Special Survey for Long Term Application

NCT01516229 ·Status: COMPLETED

Study of Skeletal Disorders and Short Stature

NCT00001754 ·Status: COMPLETED

Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation

NCT01073605 ·Status: COMPLETED ·Phase: PHASE3

Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin

NCT00488124 ·Status: COMPLETED ·Phase: PHASE2

A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin

NCT01435629 ·Status: COMPLETED

A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia

NCT05929807 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3

Molecular Basis of the Growth Axis in Short Stature

NCT00453245 ·Status: COMPLETED

Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency

NCT00191165 ·Status: COMPLETED ·Phase: PHASE3